Paid Clinical Trials in Atlanta, GA
As of September 2026, 1,484 paid clinical trials are recruiting in Atlanta, Georgia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Atlanta offers studies at sites including Emory University for conditions such as Multiple Myeloma, Breast Cancer, Sickle Cell Disease, Schizophrenia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Atlanta
Trials by drug in Atlanta
Filter results
Newly added in Atlanta
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Georgia CEAL RESTORES Family Diabetes Study
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Non-invasive Prediction of EArly Cardiac rEjection
1,338 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
A Study of Brenipatide in Adult Participants With Schizophrenia
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Top Research Study Locations in Atlanta
Researchers run research studies in Atlanta, GA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Emory University | Coronary Artery Disease, Parkinson Disease, Prostate Cancer | 219 |
| Emory University Hospital/Winship Cancer Institute | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 113 |
| Emory University Hospital Midtown | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 112 |
| Emory University Hospital | Coronary Artery Disease, Multiple Myeloma, Stroke | 98 |
| Emory Saint Joseph's Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 73 |
| Children's Healthcare of Atlanta | Sickle Cell Disease, Neuroblastoma, Autism | 59 |
| Grady Health System | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 47 |
| Northside Hospital | Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma | 45 |
| Emory University School of Medicine | Colorectal Cancer, Diabetes, Fabry Disease | 40 |
| Children's Healthcare of Atlanta - Arthur M Blank Hospital | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 36 |
| Grady Memorial Hospital | Human Immunodeficiency Virus, Intracerebral Hemorrhage, Colorectal Neoplasms | 31 |
| Winship Cancer Institute, Emory University | Advanced Solid Tumor, Breast Cancer, Endometrial Cancer | 30 |
| Winship Cancer Institute of Emory University | Multiple Myeloma, Breast Cancer, Diffuse Large B Cell Lymphoma | 27 |
| Emory Winship Cancer Institute | Ovarian Cancer, Acute Myeloid Leukemia, Breast Cancer Metastatic | 25 |
| Piedmont Healthcare | Pancreatic Ductal Adenocarcinoma (PDAC), Liver Diseases, Non-Small Cell Lung Cancer | 24 |
| Piedmont Heart Institute | Aortic Valve Stenosis, Coronary Artery Disease, Atrial Fibrillation (AF) | 23 |
| Atlanta Center for Medical Research | Schizophrenia, Bipolar Disorder, Bipolar Depression | 15 |
| Emory Proton Therapy Center | Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Advanced Hepatocellular Carcinoma | 15 |
| Piedmont Hospital | Intracranial Meningioma, Atrial Fibrillation, Postoperative, Breast Cancer | 13 |
| Morehouse School of Medicine | Crohn Disease, Bowel Cleansing for Colonoscopy, Cancer | 12 |
| Winship Cancer Institute | NSCLC (Non-small Cell Lung Cancer), Breast Cancer, Breast Neoplasms | 12 |
| Emory University Winship Cancer Institute | Advanced Solid Tumors, Autoimmune Diseases, Breast Cancer | 11 |
| Georgia State University | Adult, Cognition, Endothelial Function (Reactive Hyperemia) | 11 |
| The Emory Clinic | Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Cervical Cancer | 11 |
| Emory Clinic | Advanced Glenohumeral Osteoarthritis, Aortic Aneurysm, Abdominal, Chronic Kidney Disease | 10 |
Active & Upcoming Studies in Atlanta (2026)
Recruiting trials in Atlanta grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (447 active studies)
- A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC · Phase 2 · Jazz Pharmaceuticals
- Axatilimab + CAR-T for High-Risk Lymphoma · Phase 1 · Northside Hospital, Inc.
Cardiovascular (109 active studies)
- CGM Use in Heart Failure · Emory University
- A Plant-Based Diet in the Treatment of Coronary Microvascular Dysfunction · Emory University
Neurology & pain (81 active studies)
- Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke · Georgia Institute of Technology
- Electrophysiologic Mechanisms of Ketamine Antidepressant Response · Phase 2 · Emory University
Mental health & behavior (64 active studies)
- A Mindfulness-based Intervention for Sexual Assault Survivors · Georgia State University
- Quantifying Multi-step Avoidance in Anxiety · Emory University
Diabetes & metabolic (46 active studies)
- CGM Use in Heart Failure · Emory University
- Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems · Phase 2 · vTv Therapeutics
HIV / STI (38 active studies)
Pediatric (24 active studies)
Vaccines (18 active studies)
- A Human Influenza Transmission Study Using Naturally Infected Community Donors · Emory University
- The EMBRACE Study: Enflonsia Monoclonal in Babies - RSV Antibody Concentration Evaluation · Phase 4 · Emory University
Eye & vision (4 active studies)
- Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants · Phase 4 · Neurotech Pharmaceuticals
- 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study · Iantrek, Inc.
Common conditions studied in Atlanta
- Multiple Myeloma (27 active studies)
- Breast Cancer (21 active studies)
- Sickle Cell Disease (19 active studies)
- Schizophrenia (18 active studies)
- Acute Myeloid Leukemia (17 active studies)
- Coronary Artery Disease (16 active studies)
Leading research sponsors in Atlanta
- Emory University
- National Cancer Institute (NCI)
- AstraZeneca
- Eli Lilly and Company
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Atlanta?
There are approximately 1,484 recruiting clinical trials in Atlanta, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Atlanta pay participants?
Most recruiting trials in Atlanta compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Atlanta?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Atlanta?
The most common conditions under active study in Atlanta include Multiple Myeloma (27), Breast Cancer (21), Sickle Cell Disease (19), Schizophrenia (18), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Atlanta?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Atlanta on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Atlanta?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Atlanta?
Recruiting research sites in Atlanta include Emory University, Emory University Hospital/Winship Cancer Institute, Emory University Hospital Midtown, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Atlanta right now?
The largest active categories in Atlanta are Cancer & tumors (447), Cardiovascular (109), Neurology & pain (81). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.